Neurologist Dr. Jonathan Halford, an expert in epilepsy, describes the clinical trials effort at MUSC testing new medications for partial epilepsy. He distinguishes between two types of epilepsy medication on the basis of both cost and potential side effects and toxicity. Dr. Halford notes who qualifies for these clinical trials and provides information on how to become involved in a clinical trial through the MUSC Department of Neurosciences.